CVS Health provides $1 million+ for smoking cessation programs

Article

Community groups around the country will receive funds to support local initiatives working to prevent and end smoking.

CVS Health and its foundation are investing more than $1 million in grant support for tobacco cessation and prevention programs nationwide, a company statement announced.

The funds will be distributed to a number of healthcare and community partners that work to promote tobacco-free communities, help individuals to quit smoking, and help educate people not to start smoking. Some of the grant monies will go to support quit lines operated by National Jewish Health and the American Lung Association.

Related content: CVS Caremark changes its name, stops tobacco sales early

Other grant recipients include B’More for Healthy Babies, providing support for a smoking cessation partnership with CareFirst BlueCross BlueShield, which helps pregnant women and new mothers to stop smoking.

Another grant will support Live Well San Diego, a metropolitan-wide health and wellness initiative administered by the Department of Health, to provide smoking cessation services to 1,750 residents who are part of the behavioral health system.

Sixteen Connecticut Area Boys and Girls Clubs will receive support for their youth tobacco awareness and education program “Be Smart, Don’t Start.”

“As we mark the Great American Smokeout, CVS Health is proud to make this investment in smoking cessation programs that give people the resources and support they need to quit smoking and lead tobacco-free lives,” said Eileen Howard Boone, senior vice president of Corporate Social Responsibility and Philanthropy at CVS Health. “Our company’s purpose is helping people on their path to better health, and by supporting these dedicated community and healthcare partners, we are able to extend that purpose into our local communities.”

For a complete list of grant recipients, click here.

Recent Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.